This site uses cookies to improve your browsing experience. By continuing to browse this site you are agreeing to our use of cookies. For further information, please refer to
Privacy Policy
.
×
Shine-On BioMedical
LANGUAGE
繁體中文
English
ABOUT
Overview
Milestone
Mission
Organization
Management and consulting team
Core Technologies
Targeted exosome for drug delivery
Trispecific T cell engager antibody
R&D Pipeline
Targeted exosome for drug delivery
SOB100: HLA-G targeted exosome (αHLA-G exo)
SOB101: HLA-G targeted exosomal doxorubicin
SOB102: HLA-G targeted exosomal microRNA
SOB201: Genetically engineered stem cell-derived exosomes
Trispecific T cell engager antibody
SOA101: Nanobody-based trispecific antibody T cell engager (Nb-TriTE)
SOA201: EphA10-trispecific immune cell engager antibody
Exosome-derived products
SOC101&SOC102
Products Pipeline
News
Links
政府機構
學術機構
產業新知
Investor Zone
Sustainable development CSR
Sustainable development CSR
Ethics compliance and whistleblower protection
Stakeholders Area
Contact
Disclaimer
Terms
Privacy
R&D Pipeline
HOME
R&D Pipeline
Products Pipeline
Products Pipeline
DETAIL
Back
TOP
LANGUAGE
繁體中文
English
ABOUT
Overview
Milestone
Mission
Organization
Management and consulting team
Core Technologies
Targeted exosome for drug delivery
Trispecific T cell engager antibody
R&D Pipeline
Targeted exosome for drug delivery
SOB100: HLA-G targeted exosome (αHLA-G exo)
SOB101: HLA-G targeted exosomal doxorubicin
SOB102: HLA-G targeted exosomal microRNA
SOB201: Genetically engineered stem cell-derived exosomes
Trispecific T cell engager antibody
SOA101: Nanobody-based trispecific antibody T cell engager (Nb-TriTE)
SOA201: EphA10-trispecific immune cell engager antibody
Exosome-derived products
SOC101&SOC102
Products Pipeline
News
Links
政府機構
學術機構
產業新知
Investor Zone
Sustainable development CSR
Sustainable development CSR
Ethics compliance and whistleblower protection
Stakeholders Area
Contact
Disclaimer
Terms
Privacy
